An interventional study of low histidine diet and low tryptophan diet in Functional Dyspepsia, sponsored by University of Michigan. Not yet recruiting at 1 site in United States. Open to participants aged 18 Years to 75 Years. Per ClinicalTrials.gov, last updated 2026-11-17.
Sponsored by University of Michigan · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 77 studies in Dyspepsia with a site in United States — 14 open to participants now, 18 under way, 1 of them phase 3. Dyspepsia · United States.
Among the 77 studies in Dyspepsia with a site in United States, this one is the 43rd largest by planned enrollment of the 67 interventional ones that give a count, is one of 4 that started in 2026, is one of 34 with no phase, reaches primary completion later than 9 of the 17 other live ones, and was the 77th registered.
373 studies on the registry are indexed under Dyspepsia; 67 are open to participants now.
Browse Dyspepsia studies →14 of the 77 studies in Dyspepsia with a site in United States are open now. Recruiting first, the newest first:
Mayo Clinic · Sites in United States
Ages 18+
Ohio State University · Sites in United States
Ages 18+
Spaulding Rehabilitation Hospital · Sites in United States
Ages 18–65
Hospital Universitari Vall d'Hebron Research Institute · Sites in United States, Canada, France and 4 more countries
Ages 18–80 · Healthy volunteers
Mayo Clinic · Sites in United States
Ages 18–80
A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →
Of the 46 Dyspepsia studies recruiting now, 16 (35%) set no upper age limit and 23 (50%) stop at 75 or younger; 2 take children under 18; 8 take healthy volunteers.
This study: 18 Years to 75 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
77 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 10 · Phase 2 14 · Phase 3 13 · Phase 4 2
First in 1999; this study’s year is marked. 4 started in 2026.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 30 is below the median of 88 across 303 interventional studies indexed under Dyspepsia.
Median enrollment 50 across the 67 interventional studies, 41 across the 10 observational. Of the 52 that completed or were terminated, 14 (27%) have results posted.
This tab as a report to print or save as PDF → With an account.
18 of 77 have an industry lead sponsor. The 10 most frequent:
University of Michigan is the lead sponsor of 1,508 studies on the registry; 194 are open to participants now.
Of its 169 completed or terminated interventional studies of FDA-regulated products, 133 (79%) have results posted.
University of Michigan has 1 study filed under Dyspepsia — fewer than ten, so there is no comparison to draw.
6 of the studies in Dyspepsia with a site in United States that are under way reach primary completion within a year, 1 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT01696734Phase 3M.D. Anderson Cancer CenterDomperidone in Treating Patients With Gastrointestinal Disorders | 2027-10-31 |
| NCT05836597Mayo ClinicFunctional Dyspepsia Treatment Using Virtual Reality | 2026-12 |
| NCT06941545Mayo ClinicHigh Resolution Gastric Mapping and Gastroduodenal Manometry | 2026-12-31 |
| NCT05653310Xiao Jing (Iris) WangTradipitant for Functional Dyspepsia | 2027-03 |
| NCT05587127Massachusetts General HospitalExposure-Based CBT for Avoidant/Restrictive Food Intake in Functional Dyspepsia | 2027-05 |
Add all 6 to your calendar (.ics) → With an account.
Among the 77 studies in Dyspepsia with a site in United States, from their registry updates:
This tab as a report to print or save as PDF → With an account.
This pilot study will test whether people with functional dyspepsia can follow two new dietary approaches and whether these diets may improve symptoms. Thirty adults will be randomly assigned to follow a low-histidine diet, a low-tryptophan diet, or a comparison diet for six weeks. The study aims to reduce-not eliminate- intake. The comparison diet provides dietary instructions that are not intended to reduce either nutrient.
The main goal is to determine whether participants intake of these nutrients can change through diet approaches.
Participants will receive nutrition counseling, follow the diet assigned, describe food consumption during dietary-recall interviews, complete questionnaires, provide blood and urine samples, and swallow a capsule that measures movement and gases in the digestive tract before and after the intervention.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Approximately 10 participants between the ages of 18-75 years old.
Behavioral: low histidine diet
Approximately 10 participants between the ages of 18-75 years old.
Behavioral: low tryptophan diet
Approximately 10 participants between the ages of 18-75 years old.
Behavioral: sham diet
Histamine and histidine are used interchangeably in study materials. Participants will meet with a study team nutritionist for 30 minutes at the time of group assignment for education on dietary strategies to reduce histidine intake. Subjects will follow the diet for a total of 6 weeks between Visits 3 and 6.
Participants will meet with a study team nutritionist for 30 minutes at the time of group assignment for education on dietary strategies to reduce tryptophan intake. Subjects will follow the diet for a total of 6 weeks between Visits 3 and 6.
Participants will meet with a study team nutritionist for 30 minutes at the time of group assignment for education on dietary recommendations that will not lead to an impact in dietary histidine or tryptophan intake. Subjects will follow the diet for a total of 6 weeks between Visits 3 and 6.
Change in 24-hour dietary histidine
Histidine is assessed through 24-hour dietary recall using Nutrition Data System for Research (NDSR)
Time frame: baseline, 6 week
Change in 24-hour dietary tryptophan
Tryptophan is assessed through 24-hour dietary recall using NDSR
Time frame: baseline, 6 week
Percentage of participants who meet a 30% reduction in dietary tryptophan
Tryptophan is assessed through 24-hour dietary recall using NDSR
Time frame: 6 week
Percentage of participants who meet a 30% reduction in dietary histidine
Histidine is assessed through 24-hour dietary recall using NDSR
Time frame: 6 week
Plan to share: No
No publications or documents are linked to this record.
Start is estimated for Nov 2026; primary completion for Nov 2027, 12 months later.
Of 71 non-industry interventional studies with no phase under Dyspepsia, half reached primary completion within 18 months of starting (the median), counting those still running; a quarter within 9 and three quarters within 28. This study's planned 12 months is below that.
Counting every sponsor, half of 79 studies reached it within 17 months; a quarter within 9 and three quarters within 28.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is not yet recruiting, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.